Which are the causes of Hypereosinophilic Syndrome?

TL;DR: Hypereosinophilic syndrome (HES) is a group of rare disorders characterized by persistently high levels of eosinophils (a type of white blood cell) in the blood and their infiltration into organs, causing damage. While the exact cause remains unknown in many cases, it is often categorized into myeloid, lymphocytic, or idiopathic subtypes based on the underlying biological mechanism.

What are the primary causes of Hypereosinophilic Syndrome?

The causes of Hypereosinophilic syndrome are complex and varied, often depending on the specific subtype of the disease. In some patients, Hypereosinophilic syndrome arises from a primary bone marrow disorder where abnormal cells produce too many eosinophils. In other cases, it is reactive, meaning the body is overproducing eosinophils in response to an underlying condition such as an allergy, parasite, or malignancy. Currently, medical science classifies these causes into distinct categories:

• Myeloid HES: Caused by genetic mutations (such as FIP1L1-PDGFRA) that lead to the uncontrolled growth of eosinophils.


• Lymphocytic HES: Occurs when abnormal T-cells release cytokines that act as "growth signals" for eosinophils.


• Idiopathic HES: A diagnosis given when extensive testing fails to identify a specific underlying cause, which remains a major focus of ongoing research.

Is Hypereosinophilic Syndrome hereditary?

Most cases of Hypereosinophilic syndrome are not considered hereditary in the classic sense of being passed down from parent to child through the germline. Instead, the genetic abnormalities associated with Hypereosinophilic syndrome—such as the fusion gene FIP1L1-PDGFRA—are usually somatic mutations, meaning they are acquired during a person's lifetime within specific cells. While these mutations drive the disease, they are generally not inherited.

What is the difference between causes and risk factors?

In the context of Hypereosinophilic syndrome, a "cause" is the direct biological mechanism (like a gene mutation) triggering the overproduction of eosinophils. A "risk factor," by contrast, describes environmental or clinical conditions that might predispose an individual to develop the syndrome, such as chronic parasitic infections or certain autoimmune conditions. Understanding this distinction is vital, as Hypereosinophilic syndrome research is currently shifting toward identifying these triggers to improve early intervention.

Next steps

• Consult a hematologist or an immunologist to confirm your specific subtype through molecular testing.


• Join our community at DiseaseMaps.org to connect with others sharing their experiences with Hypereosinophilic syndrome.


• Ask your specialist about clinical trials investigating targeted kinase inhibitors or monoclonal antibodies.

Medical disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hypereosinophilic syndrome.


• Orphanet: Hypereosinophilic syndrome (ORPHA:399).


• OMIM (Online Mendelian Inheritance in Man): Entry #607202.


• American Partnership for Eosinophilic Disorders (APFED).